Biokin Pharmaceutical selects Cryoport

business deal concept

Biokin Pharmaceutical Co. Ltd. has selected Cryoport’s full suite of temperature-controlled solutions to support its Phase I and II clinical trials in immuno-oncology in both the US and China.

You must be a subscriber to read this content

If you already subscribe, please sign-in now

Subscribe to Gas World


Get instant access to must-read content today!

To access hundreds of features, subscribe today! At a time when the world is forced to go digital more than ever before just to stay connected, discover the in-depth content our subscribers receive every month by subscribing to gasworld.

Don’t just stay connected, stay at the forefront – join gasworld and become a subscriber to access all of our must-read content online from just $310.